| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3144768
Max Phase: Preclinical
Molecular Formula: C16H10ClN3O2
Molecular Weight: 311.73
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=c1[nH]c2cc(Cl)ccc2c2c(=O)n(-c3ccccc3)[nH]c12
Standard InChI: InChI=1S/C16H10ClN3O2/c17-9-6-7-11-12(8-9)18-15(21)14-13(11)16(22)20(19-14)10-4-2-1-3-5-10/h1-8,19H,(H,18,21)
Standard InChI Key: YTDGFBZNZQOLAO-UHFFFAOYSA-N
Associated Targets(non-human)
Glutamate (NMDA) receptor subunit zeta 1 2166 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 311.73 | Molecular Weight (Monoisotopic): 311.0462 | AlogP: 2.81 | #Rotatable Bonds: 1 |
| Polar Surface Area: 70.65 | Molecular Species: ACID | HBA: 3 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 3.38 | CX Basic pKa: | CX LogP: 2.44 | CX LogD: 1.21 |
| Aromatic Rings: 4 | Heavy Atoms: 22 | QED Weighted: 0.57 | Np Likeness Score: -1.02 |
References
| 1. MacLeod AM, Grimwood S, Barton C, Bristow L, Saywell KL, Marshall GR, Ball RG.. (1995) Identification of 3,5-dihydro-2-aryl-1H-pyrazolo[3,4-c]quinoline-1,4(2H)-diones as novel high-affinity glycine site N-methyl-D-aspartate antagonists., 38 (12): [PMID:7783155] [10.1021/jm00012a024] |
Source
Source(1):